This is an interview with Dr. Paul Wotton, who joined Cynata Therapeutics Board of Directors in June, 2016.  Dr. Wotton was previously President and CEO of Ocata Therapeutics, Inc. (NASDAQ: OCAT) joining the company in July 2014 and managing it through an all-cash take-over by Astellas Pharma valued at $379 million. [Read more…]
Sponsored Content: Interivews published by BioInformant are paid content. BioInformant is not responsible for the accuracy or claims made in these interviews and does not endorse the views expressed by the interviewees.
How Exosomes Are Revolutionizing Neuroimmunology with Dr. Stefano Pluchino
I am honored to release this interview with Dr. Stefano Pluchino of the highly regarded Pluchino Lab in Cambridge, UK. Dr. Pluchino received his MD and PhD degrees at the University of Siena, Italy, and additional training at Cambridge University, UK.
Dr. Pluchino is an international expert on neuroimmunology-related applications of exosomes, with his lab exploring modalities by which neural progenitor cells (NPCs) engage in cell-to-cell communication. The focus of the laboratory is to explore cellular and molecular mechanisms regulating to the therapeutic plasticity of stem cells in preclinical models of CNS conditions, including multiple sclerosis (MS), stroke, and spinal cord injury. [Read more…]
Advances in in-vitro Science are Translating to Human Outcomes with Patrick Dentinger, President & CEO
I had the honor of interviewing Patrick Dentinger, President and CEO of ACF Bioservices, an Absorption Systems company whose mission is to develop innovative research tools that can be used to accurately predict human outcomes. The company has facilities in Philadelphia, PA, Medford, MA, San Diego, CA, and Panama City, Panama.
In this fascinating interview, we discuss Mr. Dentinger’s background, the establishment of ACF, its origins in parent company Absorption Systems, and the critical role it is playing within the rapidly expanding cell- and gene-therapy industry. [Read more…]
Perinatal Stem Cells – Current and Future Landscape with Kyle Cetrulo
The Perinatal Stem Cell Society was founded on the basic principle that stem cells from perinatal tissues contain enormous, untapped potential for use in medicine. For this reason, the society hosts an annual event known as the Perinatal Stem Cell Society Congress. It includes a scientific program with topics covering all aspects of the perinatal stem cell field, with attendees advancing perinatal stem cell research and focused on paths towards treatment.
Without question, perinatal stem cells represent one of the most promising areas of stem cell research. While perinatal stem cells are largely recognized for their therapeutic potential, these cells will also shape the fields of drug discovery and toxicology.
For this reason, I am honored to share an interview below with Kyle Cetrulo, President and Founder of the Perinatal Stem Cell Society. [Read more…]
Salivary EVs, Exosomes, and the Future of Non-Invasive Diagnostics
I had the honor of interviewing Paul D Slowey, PhD, CEO of Oasis Diagnostics® Corporation, a company specializing in non-invasive saliva based technology for rapid testing, sample collection, and molecular diagnostics. Dr. Slowey is also the Organizer of the North American Saliva Symposium (NASS).
In this interview, we discuss his unique background, the rise of extracellular vesicles (EVs) and exosomes as diagnostic tools, advantages of saliva over other bodily fluids, and current and future applications for saliva-derived EVs and exosomes. [Read more…]
- « Previous Page
- 1
- …
- 9
- 10
- 11
- 12
- 13
- …
- 15
- Next Page »